JP Stock MarketDetailed Quotes

4967 Kobayashi Pharmaceutical

Watchlist
  • 5764.0
  • -17.0-0.29%
20min DelayMarket Closed Oct 4 15:00 JST
449.88BMarket Cap21.49P/E (Static)

Kobayashi Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kobayashi Pharmaceutical Q2 2024 Earnings Date

Currency：JPYAug 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
38.36B
36.65B
-1.71B
Miss Est.
-4.49%
-8.73%
-4.45%
EPS
53.15
6.19
-46.96
Miss Est.
-4.95%
-88.93%
-88.36%
Analyst Rating
Hold

Sep 30, 2024

Kobayashi Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 52.440B--
Nov 8, 20242024/Q3-- / 44.591B--
Aug 8, 20242024/Q236.651B / 38.356B--
May 10, 20242024/Q136.485B / 36.358B--
Feb 9, 20242023/Q454.340B / 54.430B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 52.440B--
Nov 8, 20242024/Q3-- / 44.591B--
Aug 8, 20242024/Q236.651B / 38.356B--
May 10, 20242024/Q136.485B / 36.358B--
Feb 9, 20242023/Q454.340B / 54.430B--

Unlock Free Earnings Estimates

Kobayashi Pharmaceutical Earnings Reports

  • Kobayashi Pharmaceutical: Interim Report - 107th Fiscal Year (January 1, 2024 - December 31, 2024)

    Aug 9 02:00 ET

  • Kobayashi Pharmaceutical: Confirmatory letter.

    Aug 9 02:00 ET

  • Kobayashi Pharmaceutical: Amended temporary report

    Aug 8 02:30 ET

  • Kobayashi Pharmaceutical: Announcement of dividends for surplus funds (interim dividends)

    Aug 8 02:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Hold

    • Strong Buy

      12.50%

    • Buy

      0.00%

    • Hold

      75.00%

    • Underperform

      0.00%

    • Sell

      12.50%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data